CoChat
Sign Up
Cited by 378Bone Metabolism and DiseasesRheumatoid Arthritis Research and TherapiesOsteomyelitis and Bone Disorders Research

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast Formation

Open access
Udagawa, Nobuyuki, Horwood, Nicole J., Elliott, Jan, Mackay, Alan, Owens, Jane, Okamura, Haruki, Kurimoto, Masashi, Chambers, Timothy J., Martin, T.  John, Gillespie, Matthew T.·1997·The Journal of Experimental Medicine
DOI 10.1084/jem.185.6.1005PMC PMC2196233
Open this paper in CoChat — free account

Abstract

We have established by differential display polymerase chain reaction of mRNA that interleukin (IL)-18 is expressed by osteoblastic stromal cells. The stromal cell populations used for comparison differed in their ability to promote osteoclast-like multinucleated cell (OCL) formation. mRNA for IL-18 was found to be expressed in greater abundance in lines that were unable to support OCL formation than in supportive cells. Recombinant IL-18 was found to inhibit OCL formation in cocultures of osteoblasts and hemopoietic cells of spleen or bone marrow origin. IL-18 inhibited OCL formation in the presence of osteoclastogenic agents including 1α,25-dihydroxyvitamin D3, prostaglandin E2, parathyroid hormone, IL-1, and IL-11. The inhibitory effect of IL-18 was limited to the early phase of the cocultures, which coincides with proliferation of hemopoietic precursors. IL-18 has been reported to induce interferon-γ (IFN-γ) and granulocyte/macrophage colony-stimulating factor (GM–CSF) production in T cells, and both agents also inhibit OCL formation in vitro. Neutralizing antibodies to GM–CSF were able to rescue IL-18 inhibition of OCL formation, whereas neutralizing antibodies to IFN-γ did not. In cocultures with osteoblasts and spleen cells from IFN-γ receptor type II–deficient mice, IL-18 was found to inhibit OCL formation, indicating that IL-18 acted independently of IFN-γ production: IFN-γ had no effect in these cocultures. Additionally, in cocultures in which spleen cells were derived from receptor-deficient mice and osteoblasts were from wild-type mice and vice versa, we identified that the target cells for IFN-γ inhibition of OCL formation were the hemopoietic cells. The work provides evidence that IL-18 is expressed by osteoblasts and inhibits OCL formation via GM–CSF production and not via IFN-γ production.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.185.6.1005

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Identification of IL-18. (A) An example of a ddPCR gel. Lanes correspond to RNA from the different sources: (lane 1) hydrocortisone-treated tsJ10 cells, (lane 2) hydrocortisone-treated tsJ14 cells, (lane 3) 1α,25(OH)2 D3- and PGE2treated tsJ2 cells, and (lane 4) 1α,25(OH)2 D3- and PGE2treated tsJ14 cells. The PCR fragment identified as IL-18 is indicated by the arrow on the left. Indicated by the arrow on the right is a PCR fragment corresponding to a hitherto uncharacterized mRNA species, which is expressed in greater abundance in the OCL-supportive cell lines. The osteoclast-supporting activity (OSA) of these cell lines is indicated below the gel: plus (supportive) or minus (nonsupportive). (B) Nucleotide sequence of mouse IL-18 (GenBankTM accession number D49949). The region corresponding to the differentially expressed PCR fragment isolated from (A) is between nucleotides 636–830. Sequences underlined correspond to oligonucleotides specific to IL-18 used for RT-PCR analysis and detection of RT-PCR products (IL-18-1, IL-18-3, and IL-18-2 from 5′ to 3′). Nucleotides in capitals corrrespond to the coding region of IL-18, whereas those in lower case correspond to the 5′ and 3′ untranslated sequences. (C) Semiquantitative RT-PCR analysis of IL-18 mRNA. PCR products for RNA isolated from different sources was reversed transcribed with oligo (dT) and PCR performed with the primers IL-18-1 and IL-18-2 for 23 cycles, which was in the log-linear range of amplification. Lanes correspond to RNA from (1) hydrocortisone-treated tsJ10 cells, (2) hydrocortisone-treated tsJ14 cells, (3) 1α,25(OH)2 D3- and PGE2-treated tsJ2 cells, and (4) 1α,25(OH)2 D3- and PGE2-treated tsJ14 cells. Resultant PCR products were electrophoresed, transferred to a nylon membrane, and hybridized with a γ-32P–labeled internal detection oligonuleotide for IL-18 (IL-18-3). Similar amplifications for GAPDH with GAPDH-2 and GAPDH-4 for 20 cycles were performed and products detected with γ-32P–labeled GAPDH-1 as previously described (30). The osteoclast-supporting activity (OSA) of these cell lines is indicated below the gel: plus (supportive) or minus (nonsupportive).
Figure 1 Identification of IL-18. (A) An example of a ddPCR gel. Lanes correspond to RNA from the different sources: (lane 1) hydrocortisone-treated tsJ10 cells, (lane 2) hydrocortisone-treated tsJ14 cells, (lane 3) 1α,25(OH)2 D3- and PGE2treated tsJ2 cells, and (lane 4) 1α,25(OH)2 D3- and PGE2treated tsJ14 cells. The PCR fragment identified as IL-18 is indicated by the arrow on the left. Indicated by the arrow on the right is a PCR fragment corresponding to a hitherto uncharacterized mRNA species, which is expressed in greater abundance in the OCL-supportive cell lines. The osteoclast-supporting activity (OSA) of these cell lines is indicated below the gel: plus (supportive) or minus (nonsupportive). (B) Nucleotide sequence of mouse IL-18 (GenBankTM accession number D49949). The region corresponding to the differentially expressed PCR fragment isolated from (A) is between nucleotides 636–830. Sequences underlined correspond to oligonucleotides specific to IL-18 used for RT-PCR analysis and detection of RT-PCR products (IL-18-1, IL-18-3, and IL-18-2 from 5′ to 3′). Nucleotides in capitals corrrespond to the coding region of IL-18, whereas those in lower case correspond to the 5′ and 3′ untranslated sequences. (C) Semiquantitative RT-PCR analysis of IL-18 mRNA. PCR products for RNA isolated from different sources was reversed transcribed with oligo (dT) and PCR performed with the primers IL-18-1 and IL-18-2 for 23 cycles, which was in the log-linear range of amplification. Lanes correspond to RNA from (1) hydrocortisone-treated tsJ10 cells, (2) hydrocortisone-treated tsJ14 cells, (3) 1α,25(OH)2 D3- and PGE2-treated tsJ2 cells, and (4) 1α,25(OH)2 D3- and PGE2-treated tsJ14 cells. Resultant PCR products were electrophoresed, transferred to a nylon membrane, and hybridized with a γ-32P–labeled internal detection oligonuleotide for IL-18 (IL-18-3). Similar amplifications for GAPDH with GAPDH-2 and GAPDH-4 for 20 cycles were performed and products detected with γ-32P–labeled GAPDH-1 as previously described (30). The osteoclast-supporting activity (OSA) of these cell lines is indicated below the gel: plus (supportive) or minus (nonsupportive).CC BY-NC-SA · PubMed Central
Figure 2 OCL formation in cocultures of mouse bone marrow and osteoblastic cells in the presence of IL-18 (A) or IFN-γ (B). Mouse bone marrow and primary osteoblastic cells were cocultured with 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M) in the presence of increasing concentrations of IL-18 (A) or IFN-γ (B). For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 and PGE2, respectively. After culture for 7 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures, and are representative of three similar experiments.
Figure 2 OCL formation in cocultures of mouse bone marrow and osteoblastic cells in the presence of IL-18 (A) or IFN-γ (B). Mouse bone marrow and primary osteoblastic cells were cocultured with 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M) in the presence of increasing concentrations of IL-18 (A) or IFN-γ (B). For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 and PGE2, respectively. After culture for 7 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures, and are representative of three similar experiments.CC BY-NC-SA · PubMed Central
Figure 3 Effect of IL-18 (10 ng/ml) on OCL formation in cocultures of mouse bone marrow and osteoblastic cells in the presence of 1α,25(OH)2 D3 (10−8 M), PGE2 (10−7 M), PTH (200 ng/ml), IL-11 (20 ng/ml), and IL-1 (100 ng/ml). After culture for 7 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures and are representative of three similar experiments.
Figure 3 Effect of IL-18 (10 ng/ml) on OCL formation in cocultures of mouse bone marrow and osteoblastic cells in the presence of 1α,25(OH)2 D3 (10−8 M), PGE2 (10−7 M), PTH (200 ng/ml), IL-11 (20 ng/ml), and IL-1 (100 ng/ml). After culture for 7 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures and are representative of three similar experiments.CC BY-NC-SA · PubMed Central
Figure 4 Effect of IL-18 and IFN-γ on OCL formation in cocultures of mouse bone marrow and osteoblastic cells during the coculture period in the absence and presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M). IL-18 (10 ng/ml) and IFN-γ (50 U/ml) were present over the entire culture period (days 0–6) or during the first 3 d (0–3) or the last 3 d (3–6). Media change occurred at day 3 of the culture. After culture for 6 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. This experiment was repeated on two further occasions with similar results.
Figure 4 Effect of IL-18 and IFN-γ on OCL formation in cocultures of mouse bone marrow and osteoblastic cells during the coculture period in the absence and presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M). IL-18 (10 ng/ml) and IFN-γ (50 U/ml) were present over the entire culture period (days 0–6) or during the first 3 d (0–3) or the last 3 d (3–6). Media change occurred at day 3 of the culture. After culture for 6 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. This experiment was repeated on two further occasions with similar results.CC BY-NC-SA · PubMed Central
Figure 5 Effect of neutralizing antibodies against IL-18 or IFN-γ in rescuing OCL formation in cocultures of mouse bone marrow and osteoblastic cells treated with IL-18 or IFN-γ. Cocultures were incubated in the presence or absence of IL-18 (10 ng/ml) and IFN-γ (50 U/ml) and the effect of antibodies against IL-18 (A) or IFN-γ (B) were determined. For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M), respectively. After culture for 7 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. This experiment was repeated twice.
Figure 5 Effect of neutralizing antibodies against IL-18 or IFN-γ in rescuing OCL formation in cocultures of mouse bone marrow and osteoblastic cells treated with IL-18 or IFN-γ. Cocultures were incubated in the presence or absence of IL-18 (10 ng/ml) and IFN-γ (50 U/ml) and the effect of antibodies against IL-18 (A) or IFN-γ (B) were determined. For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M), respectively. After culture for 7 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. This experiment was repeated twice.CC BY-NC-SA · PubMed Central
Figure 6 OCL formation in cocultures of spleen cells and osteoblastic cells derived from IFN-γ receptor type II knockout (IFN-γ R −/−) mice. IL-18 (10 ng/ml) or IFN-γ (50 U/ml) were present over the entire culture period. For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M), respectively. After culture for 7 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. This experiment was repeated twice.
Figure 6 OCL formation in cocultures of spleen cells and osteoblastic cells derived from IFN-γ receptor type II knockout (IFN-γ R −/−) mice. IL-18 (10 ng/ml) or IFN-γ (50 U/ml) were present over the entire culture period. For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M), respectively. After culture for 7 d, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. This experiment was repeated twice.CC BY-NC-SA · PubMed Central
Figure 7 OCL formation in cocultures of normal C57/BL6 mousederived spleen cells with osteoblastic cells derived from IFN-γ R−/− mice and cocultures of normal C57BL/J6 mouse-derived osteoblastic cells with spleen cells derived from IFN-γ R−/− mice. Cocultures were performed in the presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M) and treated with IL-18 (10 ng/ml) or IFN-γ (50 U/ml). For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 and PGE2, respectively. After culture for 7 d, TRAPpositive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. This experiment was repeated twice.
Figure 7 OCL formation in cocultures of normal C57/BL6 mousederived spleen cells with osteoblastic cells derived from IFN-γ R−/− mice and cocultures of normal C57BL/J6 mouse-derived osteoblastic cells with spleen cells derived from IFN-γ R−/− mice. Cocultures were performed in the presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M) and treated with IL-18 (10 ng/ml) or IFN-γ (50 U/ml). For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 and PGE2, respectively. After culture for 7 d, TRAPpositive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. This experiment was repeated twice.CC BY-NC-SA · PubMed Central
Figure 8 Effect of neutralizing antibodies against GM–CSF to rescue OCL formation in cocultures of mouse bone marrow and osteoblastic cells treated with GM–CSF (0.1 ng/ml), IL-18 (10 ng/ml), or IFN-γ (50 U/ml). Cocultures were incubated in the presence or absence of GM– CSF, IL-18, or IFN-γ and the effect of neutralizing antibodies to GM– CSF (1 μg/ml) were determined. For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M), respectively. After culture for 7 d, TRAPpositive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. Similar results were obtained with three repeat experiments.
Figure 8 Effect of neutralizing antibodies against GM–CSF to rescue OCL formation in cocultures of mouse bone marrow and osteoblastic cells treated with GM–CSF (0.1 ng/ml), IL-18 (10 ng/ml), or IFN-γ (50 U/ml). Cocultures were incubated in the presence or absence of GM– CSF, IL-18, or IFN-γ and the effect of neutralizing antibodies to GM– CSF (1 μg/ml) were determined. For negative and positive controls, cocultures were performed in the absence and presence of 1α,25(OH)2 D3 (10−8 M) and PGE2 (10−7 M), respectively. After culture for 7 d, TRAPpositive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. Similar results were obtained with three repeat experiments.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

Sorted by citations

Items 301–376 of 376

Related

See all

Metadata

Authors
Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J., & Gillespie, M. T.
Affiliations
Hyogo Medical University (JP)
ORCID
Venue
The Journal of Experimental Medicine
Publisher
Rockefeller University Press
Published
1997-03-17
Volume
185
Issue
6
Pages
1005-1012
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
DOI
10.1084/jem.185.6.1005
PMC
PMC2196233
OpenAlex
W2119656862
Cited by
378
References
35
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 2 · 2021: 6 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 3 · 2014: 10 · 2013: 9 · 2012: 13
FWCI
9.02
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
Keywords
IL-18, osteoblasts, osteoclastogenesis, osteoclast-like multinucleated cells, GM-CSF, interferon-gamma, bone remodeling, osteoclastogenesis inhibition
MeSH terms
Interferon gamma Receptor, Animals, Animals, Newborn, Base Sequence, Bone Marrow Cells, Cell Differentiation, Interferon-gamma, Male, Mice, Inbred C57BL, Molecular Sequence Data, Osteoblasts, Osteoclasts, Recombinant Proteins, RNA, Messenger, Transcription, Genetic, Polymerase Chain Reaction, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Interleukin-11, Receptors, Interferon, Mice, Knockout, Coculture Techniques, Interleukin-18, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review